Cargando…

A systematic review of GWAS identified SNPs associated with outcomes of medications for opioid use disorder

BACKGROUND: Patients with opioid use disorder (OUD) display an interindividual variability in their response to medications for opioid use disorder (MOUD). A genetic basis may explain the variability in this response. However, no consensus has been reached regarding which genetic variants significan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chawar, Caroul, Hillmer, Alannah, Sanger, Stephanie, D’Elia, Alessia, Panesar, Balpreet, Guan, Lucy, Xie, Dave Xiaofei, Bansal, Nandini, Abdullah, Aamna, Kapczinski, Flavio, Pare, Guillaume, Thabane, Lehana, Samaan, Zainab
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627063/ https://www.ncbi.nlm.nih.gov/pubmed/34838141 http://dx.doi.org/10.1186/s13722-021-00278-y

Ejemplares similares

GWAS-identified genetic variants associated with medication-assisted treatment outcomes in patients with opioid use disorder: a systematic review and meta-analysis protocol
por: Chawar, Caroul, et al.
Publicado: (2020)

Genetic determinants of cannabis use: a systematic review protocol
por: Hillmer, Alannah, et al.
Publicado: (2020)

Implications of OPRM1 and CYP2B6 variants on treatment outcomes in methadone-maintained patients in Ontario: Exploring sex differences
por: Chawar, Caroul, et al.
Publicado: (2021)

Genetic basis of cannabis use: a systematic review
por: Hillmer, Alannah, et al.
Publicado: (2021)

The Role of Perceived Social Support in the Association Between Stressful Life Events and Suicidal Behavior
por: Panesar, Balpreet, et al.
Publicado: (2021)

Identifying patient-important outcomes for treatment of bipolar disorder: a systematic review protocol
por: D'Elia, Alessia, et al.
Publicado: (2021)

The future of precision medicine in opioid use disorder: inclusion of patient-important outcomes in clinical trials
por: Sanger, Nitika, et al.
Publicado: (2020)

Genetics of cannabis use in opioid use disorder: A genome-wide association and polygenic risk score study
por: Hillmer, Alannah, et al.
Publicado: (2023)

Factors associated with opioid overdose during medication-assisted treatment: How can we identify individuals at risk?
por: Au, Vivian Y. O., et al.
Publicado: (2021)

The association between health conditions and cannabis use in patients with opioid use disorder receiving methadone maintenance treatment
por: Shams, Ieta, et al.
Publicado: (2019)

Outcomes reported in randomised controlled trials of major depressive disorder in older adults: protocol for a methodological review
por: Rodrigues, Myanca, et al.
Publicado: (2021)

Treatment Outcomes in Patients With Opioid Use Disorder Who Were First Introduced to Opioids by Prescription: A Systematic Review and Meta-Analysis
por: Sanger, Nitika, et al.
Publicado: (2020)

Delirium and other neuropsychiatric manifestations of COVID-19 infection in people with preexisting psychiatric disorders: a systematic review
por: van Reekum, Emma A., et al.
Publicado: (2021)

Association between vaping and health outcomes in patients with opioid use disorder: a systematic review protocol
por: Sanger, Nitika, et al.
Publicado: (2021)

Factors affecting participant recruitment and retention in borderline personality disorder research: a feasibility study
por: Woo, Julia, et al.
Publicado: (2021)

Cannabis use in patients treated for opioid use disorder pre- and post-recreational cannabis legalization in Canada
por: Rosic, Tea, et al.
Publicado: (2021)

The Inclusion of Patients’ Reported Outcomes to Inform Treatment Effectiveness Measures in Opioid Use Disorder. A Systematic Review
por: Sanger, Nitika, et al.
Publicado: (2022)

Patient-Reported Goals of Youths in Canada Receiving Medication-Assisted Treatment for Opioid Use Disorder
por: Chai, Darren, et al.
Publicado: (2021)

The association between cannabis use and outcome in pharmacological treatment for opioid use disorder
por: Rosic, Tea, et al.
Publicado: (2021)

Corrigendum to ‘A comparison of electronically-delivered and face to face cognitive behavioural therapies in depressive disorders: A systematic review and meta-analysis’ [EClinicalMedicine 24 (2020) 100442]
por: Sanger, Nitika, et al.
Publicado: (2021)

Cannabis use and opioid relapse: An exploratory survival analysis of prospectively collected data
por: Naji, Leen, et al.
Publicado: (2022)

Are patients’ goals in treatment associated with expected treatment outcomes? Findings from a mixed-methods study on outpatient pharmacological treatment for opioid use disorder
por: Rosic, Tea, et al.
Publicado: (2021)

National suicide management guidelines recommending family-based prevention, intervention and postvention and their association with suicide mortality rates: systematic review
por: Panesar, Balpreet, et al.
Publicado: (2022)

Evaluation of BDNF as a Biomarker for Impulsivity in a Psychiatric Population
por: Pasyk, Stanislav, et al.
Publicado: (2020)

National suicide management guidelines with family as an interv’ention and suicide mortality rates: a systematic review protocol
por: Panesar, Balpreet, et al.
Publicado: (2020)

A call for consensus in defining efficacy in clinical trials for opioid addiction: combined results from a systematic review and qualitative study in patients receiving pharmacological assisted therapy for opioid use disorder
por: Dennis, Brittany B., et al.
Publicado: (2020)

The Role of Cannabis Use in Suicidal Ideation Among Patients With Opioid Use Disorder
por: Naji, Leen, et al.
Publicado: (2021)

Investigating and addressing the immediate and long-term consequences of the COVID-19 pandemic on patients with substance use disorders: a scoping review and evidence map protocol
por: Naji, Leen, et al.
Publicado: (2021)

Impact of COVID-19 and other pandemics and epidemics on people with pre-existing mental disorders: a systematic review protocol and suggestions for clinical care
por: Sergeant, Anjali, et al.
Publicado: (2020)

The association between cannabis use and suicidal behavior in patients with psychiatric disorders: an analysis of sex differences
por: Naji, Leen, et al.
Publicado: (2018)

Social functioning outcomes in men and women receiving medication-assisted treatment for opioid use disorder
por: van Reekum, Emma A., et al.
Publicado: (2020)

Impact of ABCB1 and CYP2B6 Genetic Polymorphisms on Methadone Metabolism, Dose and Treatment Response in Patients with Opioid Addiction: A Systematic Review and Meta-Analysis
por: Dennis, Brittany B., et al.
Publicado: (2014)

Exploring psychological symptoms and associated factors in patients receiving medication-assisted treatment for opioid-use disorder
por: Rosic, Tea, et al.
Publicado: (2020)

Sociodemographic characteristics of patients with children in a methadone maintenance program: a cross-sectional study
por: Luo, Candice, et al.
Publicado: (2019)

Sensitivity and specificity of self-reported psychiatric diagnoses amongst patients treated for opioid use disorder
por: Leung, Kelly, et al.
Publicado: (2021)

The effect of cannabis exposure on pubertal outcomes: a systematic review
por: Sims, E Danielle, et al.
Publicado: (2018)

Association between cannabis use and methadone maintenance treatment outcomes: an investigation into sex differences
por: Zielinski, Laura, et al.
Publicado: (2017)

Sex differences in outcomes of methadone maintenance treatment for opioid addiction: a systematic review protocol
por: Bawor, Monica, et al.
Publicado: (2014)

Evaluation of clinical and inflammatory profile in opioid addiction patients with comorbid pain: results from a multicenter investigation
por: Dennis, Brittany B, et al.
Publicado: (2014)

The association of lncRNA SNPs and SNPs‐environment interactions based on GWAS with HBV‐related HCC risk and progression
por: Liu, Qing, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s7o43og2f99laj3m8177n44fto